Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vaxart Inc VXRT

Healthcare Biotechnology
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its programs include tablet vaccine candidates designed to protect against norovirus, coronavirus, seasonal influenza, and respiratory syncytial virus (RSV), as well as a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VXRT)

Vaxart Provides Business Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire November 2, 2023

Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

GlobeNewswire November 2, 2023

Vaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2

GlobeNewswire October 26, 2023

Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19

GlobeNewswire October 11, 2023

Vaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare Conference

GlobeNewswire September 21, 2023

Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine Candidate

GlobeNewswire September 6, 2023

Vaxart Provides Business Update and Reports Second Quarter 2023 Financial Results

GlobeNewswire August 3, 2023

Vaxart to Host Second Quarter 2023 Business Update and Financial Results Conference Call on August 3

GlobeNewswire July 27, 2023

Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine Candidate

GlobeNewswire July 6, 2023
View More News ››

Opinion & Analysis (NDAQ:VXRT)

Vaxart Shares Rise 95% After Signing Agreement for Oral Tablet COVID-19 Vaccine

Streetwise Reports June 26, 2020
View More Opinion ››

Bullboard Posts (NDAQ:VXRT)

Oral Vaccine news

Once again VXRT gets no respect
Red~One - September 9, 2022

Vaxart petition to improve IR/PR

Hi all. Just sharing a petition that is circulating online; asking Vaxart to improve its IR/PR representation. https://chng.it/QHTshgNBpb
Vaxartbzdv - January 27, 2022

VXRT......on watch

Been a high volume trader recently  No chasing
Iseneschal - May 4, 2021

Mirror image of things to come...

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a...
ITSUP2ME - March 16, 2021

VXRT - Institutional Investors

Let’s put into perspective the VXRT-State Street, BlackRock and Vanguard investments - three (3) of largest asset management and...
thevisionary2k - February 12, 2021

VXRT - StockInvest US

This morning StockInvest US released a VXRT stock and trend analysis, which included the following:   “Given the current short...
thevisionary2k - February 11, 2021
View more Bullboard ››

Acceleware Ltd

Acceleware Ltd

Acceleware Ltd. is a Canada-based company that develops clean-tech decarbonization technologies. The Company has two business ...
View More »